Pfizer shares trim most of early gains, end 3 Percent Higher
New Delhi: Shares of drug firm Pfizer trimmed most of its early gains and ended 3 per cent higher on emergence of profit-booking.
The stock which surged 7.15 per cent to Rs 1,785.80 in intra-day trade, later ended at Rs 1,712.45, up 2.75 per cent on BSE.
On NSE, shares of the company went up by 3 per cent to close at Rs 1,717.55.
The company is well placed to grow the Neksium brand further through its existing reach, coverage and equity in the gastrointestinal therapy area, Pfizer said in a statement yesterday.
Pfizer Ltd MD S Sridhar said: "The Neksium acquisition is aligned with our stated ambition of portfolio expansion through organic and inorganic growth in our focus therapy areas".
With this acquisition, the company will accelerate growth and strengthen its leadership position in the gastrointestinal (GI) therapy area, he added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd